— The India Meteorological Department (IMD) announced that the existing deep depression will likely intensify into a cyclone by Wednesday, with the storm expected to approach the Tamil Nadu coast ...

How Does One Nation, One Subscription Work? The scheme will be implemented through a unified digital portal, which will be managed by INFLIBNET (Information and Library Network), an autonomous ...

May I remind you, sir, that the UPSC is a body created under Article 315 of the Constitution. Nine articles (315 to 323) cover not just the establishment of the UPSC but also provisions relating to ...

Everyone knows the Neanderthals, homo sapiens, and Denisovans are amongst the first human species. The sapiens are considered the modern humans in that grouping that migrated out of Africa.

So how can we tell them apart from the human voice? These days it's quite easy to strike up a conversation with AI. Ask a question of some chatbots, and they'll even provide an engaging response ...

The days blur together as we watch unfold what Francesca Albanese, the United Nations special rapporteur on human rights in the occupied Palestinian territories, describes “as reasonable grounds to ...

The UPSC ESE 2024 final result has been declared and 206 candidates have been selected for the appointment with Rohit Dhondge topping the exam. Listen to Story UPSC ESE 2024 result declared; 206 ...

Once Human might have slowed down a touch from launch, but the free-to-play game is still riding high. Of course, that also means a flood of player feedback. In a new blog, developer Starry Studio ...

Fifty years ago, a remarkable fossil was unearthed in the Afar Rift Valley of Ethiopia, forever transforming our understanding of human evolution. Uncovered by a young paleoanthropologist ...

The President of the UN Human Rights Council has a critical mission: fostering consensus among Member States on pivotal human rights issues while navigating geopolitical tensions that often threaten ...

Perspective Therapeutics (NYSE:CATX) lost ~22% in the premarket on Thursday after the cancer drug developer posted results from its ongoing Phase 1/2a clinical trial for its radiopharmaceutical ...